BCHE and early-onset autosomal dominant Alzheimer disease: By inhibiting key enzymes like acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and glycogen synthase kinase-3β (GSK-3β), they help prevent the formation of β-amyloid plaques, a hallmark of Alzheimer’s disease [10].